share_log

Mayfair Advisory Group LLC Purchases 2,245 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Mayfair Advisory Group LLC Purchases 2,245 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

梅費爾諮詢集團有限責任公司購買 2,245 股丹特普利西羅納公司(納斯達克:X 射線)
Financial News Live ·  2023/02/04 10:32

Mayfair Advisory Group LLC boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 28.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,190 shares of the medical instruments supplier's stock after purchasing an additional 2,245 shares during the period. Mayfair Advisory Group LLC's holdings in DENTSPLY SIRONA were worth $297,000 as of its most recent SEC filing.

根據梅菲爾諮詢集團最近向美國證券交易委員會提交的13F文件,該公司在第三季度將其在DENTSPLY SIRONA Inc.(納斯達克:XRAY-GET評級)的股票頭寸提高了28.3%。該基金在此期間額外購買了2245股後,擁有這家醫療器械供應商的10190股股票。截至最近提交給美國證券交易委員會的文件,梅菲爾諮詢集團持有的DENTSPLY SIRONA股份價值29.7,000美元。

Several other hedge funds also recently added to or reduced their stakes in the company. Macquarie Group Ltd. boosted its position in DENTSPLY SIRONA by 3.2% in the 2nd quarter. Macquarie Group Ltd. now owns 8,879 shares of the medical instruments supplier's stock valued at $318,000 after buying an additional 274 shares during the period. Park Avenue Securities LLC boosted its position in DENTSPLY SIRONA by 4.6% in the 2nd quarter. Park Avenue Securities LLC now owns 6,403 shares of the medical instruments supplier's stock valued at $229,000 after buying an additional 280 shares during the period. S&CO Inc. boosted its position in DENTSPLY SIRONA by 0.5% in the 2nd quarter. S&CO Inc. now owns 85,747 shares of the medical instruments supplier's stock valued at $3,063,000 after buying an additional 400 shares during the period. Mutual of America Capital Management LLC boosted its position in DENTSPLY SIRONA by 1.5% in the 3rd quarter. Mutual of America Capital Management LLC now owns 29,893 shares of the medical instruments supplier's stock valued at $847,000 after buying an additional 452 shares during the period. Finally, Diversified Trust Co boosted its position in DENTSPLY SIRONA by 2.5% in the 3rd quarter. Diversified Trust Co now owns 19,140 shares of the medical instruments supplier's stock valued at $543,000 after buying an additional 472 shares during the period. 98.52% of the stock is currently owned by institutional investors.

其他幾家對衝基金最近也增持或減持了該公司的股份。麥格理集團(Macquarie Group Ltd.)第二季度將其在DENTSPLY SIRONA的頭寸增加了3.2%。麥格理集團(Macquarie Group Ltd.)目前持有這家醫療器械供應商的8,879股股票,價值31.8萬美元,在此期間又購買了274股。Park Avenue Securities LLC在第二季度將其在DENTSPLY SIRONA的頭寸增加了4.6%。Park Avenue Securities LLC現在擁有這家醫療器械供應商6,403股股票,價值22.9萬美元,在此期間又購買了280股。S&CO Inc.在第二季度將其在DENTSPLY SIRONA的頭寸增加了0.5%。S&CO Inc.現在持有這家醫療器械供應商85,747股股票,價值3,063,000美元,在此期間又購買了400股。美國互惠資本管理有限責任公司在第三季度將其在DENTSPLY SIRONA的頭寸增加了1.5%。美國互惠資本管理有限責任公司在此期間又購買了452股,現在擁有29,893股這家醫療器械供應商的股票,價值847,000美元。最後,多元化信託公司在第三季度將其在DENTSPLY SIRONA的頭寸增加了2.5%。多元化信託公司現在擁有這家醫療器械供應商的19,140股票,價值543,000美元,在此期間又購買了472股。目前,該公司98.52%的股份由機構投資者持有。

Get
到達
DENTSPLY SIRONA
Dentsply SIRONA
alerts:
警報:

Wall Street Analyst Weigh In

華爾街分析師也加入進來

Several research firms have issued reports on XRAY. StockNews.com began coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, October 12th. They issued a "hold" rating for the company. UBS Group lowered their price target on shares of DENTSPLY SIRONA to $35.00 in a research report on Thursday, November 17th. William Blair raised shares of DENTSPLY SIRONA from an "underperform" rating to a "market perform" rating in a research report on Wednesday, January 11th. Evercore ISI upped their price target on shares of DENTSPLY SIRONA to $34.00 in a research report on Thursday, November 17th. Finally, The Goldman Sachs Group lowered their price target on shares of DENTSPLY SIRONA from $41.00 to $34.00 and set a "neutral" rating for the company in a research report on Wednesday, November 16th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and an average target price of $40.70.

幾家研究公司已經發布了關於X射線的報告。StockNews.com在10月12日星期三的一份研究報告中開始報道DENTSPLY SIRONA的股票。他們對該公司的評級為“持有”。瑞銀集團在11月17日星期四的一份研究報告中將DENTSPLY SIRONA的股票目標價下調至35.00美元。在1月11日星期三的一份研究報告中,威廉·布萊爾將DENTSPLY SIRONA的股票評級從“表現不佳”上調至“市場表現”。在11月17日星期四的一份研究報告中,Evercore ISI將DENTSPLY SIRONA的股票目標價上調至34.00美元。最後,高盛夫婦在11月16日星期三的一份研究報告中將DENTSPLY SIRONA的股票目標價從41.00美元下調至34.00美元,並將該公司的評級定為“中性”。7名股票研究分析師對該股的評級為持有,3名分析師對該公司的評級為買入。根據MarketBeat.com的數據,DENTSPLY SIRONA目前的平均評級為持有,平均目標價為40.70美元。

DENTSPLY SIRONA Stock Performance

Dentsply SIRONA股票表現

DENTSPLY SIRONA stock traded down $1.22 during mid-day trading on Friday, reaching $38.44. 1,525,744 shares of the company traded hands, compared to its average volume of 1,820,563. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.50 and a quick ratio of 1.04. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.48 and a fifty-two week high of $58.70. The company has a market capitalization of $8.26 billion, a price-to-earnings ratio of 14.04, a price-to-earnings-growth ratio of 5.42 and a beta of 0.94. The firm's fifty day moving average is $33.43 and its two-hundred day moving average is $32.57.
Dentsply SIRONA的股票在週五午盤交易中下跌1.22美元,至38.44美元。該公司1,525,744股易手,而其平均成交量為1,820,563股。該公司的債務權益比為0.48,流動比率為1.50,速動比率為1.04。Dentsply SIRONA Inc.的股價為26.48美元,為52周低點,52周高點為58.70美元。該公司市值為82.6億美元,市盈率為14.04倍,市盈率為5.42倍,貝塔係數為0.94。該公司的50日移動均線切入位在33.43美元,200日移動均線切入位在32.57美元。

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.59 by ($0.18). DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The company had revenue of $947.00 million for the quarter, compared to analyst estimates of $1.01 billion. During the same quarter in the previous year, the company posted $0.68 EPS. The company's revenue for the quarter was down 8.9% compared to the same quarter last year. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.96 earnings per share for the current fiscal year.

Dentsply SIRONA(納斯達克:XRAY-GET評級)上一次發佈季度收益報告是在11月14日(星期一)。這家醫療器械供應商公佈本季度每股收益(EPS)為0.41美元,低於分析師普遍預期的0.59美元(0.18美元)。Dentsply SIRONA的淨利潤率為負20.81%,股本回報率為正9.63%。該公司本季度營收為9.47億美元,而分析師預期為10.1億美元。去年同期,該公司公佈的每股收益為0.68美元。與去年同期相比,該公司本季度的收入下降了8.9%。股票研究分析師平均預計,DENTSPLY SIRONA Inc.本財年每股收益將達到1.96美元。

DENTSPLY SIRONA Announces Dividend

Dentsply SIRONA宣佈分紅

The business also recently declared a quarterly dividend, which was paid on Friday, January 13th. Shareholders of record on Friday, December 30th were paid a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, December 29th. This represents a $0.50 dividend on an annualized basis and a yield of 1.30%.

該公司最近還宣佈了季度股息,股息於1月13日星期五支付。12月30日(星期五)登記在冊的股東獲得了每股0.125美元的股息。本次股息除息日期為12月29日星期四。這意味着年化股息為0.50美元,收益率為1.30%。

About DENTSPLY SIRONA

關於DENTSPLY SIRONA

(Get Rating)

(獲取評級)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.

Dentsply Sirona,Inc.從事專業牙科產品和技術的設計、製造、銷售和分銷。它通過以下部分運作:技術和設備以及消耗品。技術和設備部門包括牙科技術、設備和醫療消耗品,如牙科植入物、實驗室牙科產品、計算機輔助設計和計算機輔助製造系統、成像系統、治療中心和消耗性醫療器械產品。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
  • MarketBeat Week in Review – 1/30 – 2/3
  • Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
  • Zimmer Biomet Beats on Earnings, Growth May be Priced In
  • AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
  • Ford Stock Going Forward After Big Earnings Flop
  • 免費獲取StockNews.com關於DENTSPLY SIRONA(XRAY)的研究報告
  • 市場回顧周-1/30-2/3
  • 細價股值得嗎?你應該投資細價股嗎?
  • Zimmer Biomet盈利節節攀升,增長可能被計入價格
  • 人工智能軟件製造商EPAM號稱科技板塊漲幅最大
  • 福特股票在盈利大幅下滑後繼續前進

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

接收DENTSPLY SIRONA日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對DENTSPLY SIRONA和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論